Bahram Valamehr - 14 Jun 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Chief Development Officer
Signature
/s/ Cindy Tahl, Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
14 Jun 2021
Net transactions value
-$2,162,049
Form type
4
Filing time
16 Jun 2021, 16:26:36 UTC
Next filing
14 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $46,852 +16,156 +17% $2.90 111,896 14 Jun 2021 Direct F1
transaction FATE Common Stock Options Exercise $24,144 +8,844 +7.9% $2.73 120,740 14 Jun 2021 Direct F1
transaction FATE Common Stock Sale $1,459,587 -16,380 -14% $89.11* 104,360 14 Jun 2021 Direct F1, F2
transaction FATE Common Stock Sale $737,155 -8,220 -7.9% $89.68* 96,140 14 Jun 2021 Direct F1, F3
transaction FATE Common Stock Sale $36,303 -400 -0.42% $90.76* 95,740 14 Jun 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -16,156 -100% $0.000000* 0 14 Jun 2021 Common Stock 16,156 $2.90 Direct F1, F5
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -8,844 -7.4% $0.000000 111,156 14 Jun 2021 Common Stock 8,844 $2.73 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020.
F2 Represents the weighted average sale price of the shares sold from $88.45 to $89.44 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4.
F3 Represents the weighted average sale price of the shares sold from $89.45 to $90.16 per share.
F4 Represents the weighted average sale price of the shares sold from $90.71 to $90.86 per share.
F5 This option is fully vested.